ArticlePolymers2026
Multifunctional Prussian-Blue-Based Hydrogel for Photothermal Antibacterial and Infected Wound Regeneration.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To address the challenges associated with prolonged inflammatory phases and delayed healing in clinically infected wounds, this research developed a multifunctional PB@GC@OD hydrogel integrating self-healing properties, injectability, and photothermal antibacterial efficacy. The hydrogel was constructed using oxidized dextran (OD) and glycol chitosan (GC) as the matrix, which were dynamically cross-linked via a Schiff-base reaction to form the GC@OD hydrogel. Subsequently, the photothermal agent prussian blue (PB) was incorporated to fabricate the PB@GC@OD hydrogel. The resulting PB@GC@OD hydrogel demonstrated robust self-healing capabilities and excellent injectability. Upon exposure to 808 nm near-infrared (NIR) irradiation, the hydrogel achieved efficient photothermal conversion, rapidly inducing localized hyperthermia that effectively eliminated
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.